We provide you with the best medicine purchasing service
Quickly morph client-centric results through performance based applications. Proactively facilitate professional human capital for cutting-edge.
Download Now
Alglucosidase-alpha (Myozyme®)
Pompe disease (GSD II)
20mg/kg every 2 weeks IV infusion over 4 hours.(5-7)
50 mg single-use vials for reconstitution to yield (5mg/mL)
IV
|
|
Pneumonia, respiratory failure, respiratory distress,catheter-related infection, respiratory syncytial virus infection, gastroenteritis, fever and infusion reactions.
1b
5. Fernandes J, Saudubray JM, Van den Berghe G. Inborn metabolic diseases : diagnosis and treatment. 3rd rev. ed. Berlin ; New York ; London: Springer, 2000.
6. Blau N. Physician's guide to the treatment and follow-up of metabolic diseases. Berlin: Springer, 2006.
7. Saudubray JM, Van den Berghe G, Walter J. Inborn metabolic diseases : diagnosis and treatment. 5th ed. Berlin: Springer, 2012.